Practically speaking about lupus anticoagulants and women's health:
Part 1 of a series to learn about a paradoxical problem
Lupus anticoagulants are consistently present in patients at risk of thrombosis as a result of underlying antiphospholipid syndrome (aPS), a dangerous disorder treated by prophylactic anticoagulation using well-established methods. Our webinar, part of an ongoing series will give an overview of antiphospholipid syndrome, available clotting-based methods, validation procedures, and link in relevance to women’s health. The information provided will bring together different pieces of the overall but paradoxical picture of aPS, allowing for a full picture of the relevance in the overall care pathway.